Acceptable plasma concentrations of raltegravir and etravirine when administered by gastrostomy tube in a patient with advanced multidrug-resistant human immunodeficiency virus infection
about
Pharmacokinetics of Once-Daily Darunavir/Ritonavir With and Without Etravirine in Human Immunodeficiency Virus-Infected Children, Adolescents, and Young Adults.Orogastric administration of crushed darunavir tablets for a critically ill patient.Acute Care Management of the HIV-Infected Patient: A Report from the HIV Practice and Research Network of the American College of Clinical Pharmacy.A HAART-Breaking Review of Alternative Antiretroviral Administration: Practical Considerations with Crushing and Enteral Tube Scenarios.Dual therapy with etravirine plus raltegravir for virologically suppressed HIV-infected patients: a pilot study.Decreased Absorption of Dolutegravir and Tenofovir Disoproxil Fumarate, But Not Emtricitabine, in an HIV-Infected Patient Following Oral and Jejunostomy-Tube Administration.
P2860
Acceptable plasma concentrations of raltegravir and etravirine when administered by gastrostomy tube in a patient with advanced multidrug-resistant human immunodeficiency virus infection
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Acceptable plasma concentratio ...... munodeficiency virus infection
@en
Acceptable plasma concentratio ...... unodeficiency virus infection.
@nl
type
label
Acceptable plasma concentratio ...... munodeficiency virus infection
@en
Acceptable plasma concentratio ...... unodeficiency virus infection.
@nl
prefLabel
Acceptable plasma concentratio ...... munodeficiency virus infection
@en
Acceptable plasma concentratio ...... unodeficiency virus infection.
@nl
P2093
P2860
P356
P1433
P1476
Acceptable plasma concentratio ...... munodeficiency virus infection
@en
P2093
Courtney V Fletcher
Edward P Acosta
Ryan Moore
Uriel Sandkovsky
P2860
P304
P356
10.1002/PHAR.1015
P407
P577
2012-02-01T00:00:00Z